Retired boxer Mike Tyson has delivered his message to reschedule, and ultimately legalize, marijuana to President Donald Trump on one of his most-watched TV networks: Fox News.
Days after leading a letter alongside other professional athletes and celebrities promoting cannabis reform that was sent to Trump on Friday, Tyson joined FOX & Friends on Monday where he made made the case for rescheduling marijuana, expanding clemency and allowing licensed cannabis businesses to access the banking system.
“Cannabis is in the same category as heroin. How do you categorize it with heroin?” he said. “Anybody that ever smoked cannabis knows there’s no comparison and that it’s just ridiculous.”
Tyson reiterated his support for moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA)—a reform that was initiated under the Biden administration but has since stalled at the Drug Enforcement Administration (DEA). And he also stressed the economic opportunity of changing federal marijuana laws for state-licensed businesses.
“There’s over 500,000 people that can’t get loans in the cannabis business alone, and that’s just so ridiculous,” Tyson, who owns the marijuana company Tyson 2.0, said. “It’s such a great income for the country. And I just can’t see it. It’s ridiculous.”
He added that advocates are “also working on clemency, because there’s people that still in prison—been in there for 15 years, got enormous amount of time and ridiculous sentences—for cannabis.”
Tyson also argued that “the first mistake that we’re making is categorizing [marijuana] as a drug. It’s not a drug. It’s a medicine.” And he said his personal experience with cannabis is a testament to that, pointing out that he was “going crazy” as a young adult before he started consuming marijuana for its therapeutic benefits.
Asked whether he feels the plant should be fully legalized nationwide, Tyson said “100 percent yes,” in large part because “the time and the sentences” that people criminalized over cannabis have received are “just totally ridiculous.”
The boxer cited the criminal justice reform advocate and former federal cannabis prisoner Weldon Angelos as an example. Angelos helped organize the letter to Trump, who pardoned him over a cannabis-related offense during his first term.
Tyson, along with Acting U.S. Attorney for the District of New Jersey Alina Habba, also recently toured a Drug Enforcement Administration (DEA) lab. And during his Fox News interview, he echoed points from that tour, asserting that illicit operators from China and Mexico are “filling our cannabis with fentanyl and pesticides and all that stuff, and it’s just killing human beings.”
Throughout the talk, Tyson stressed that he feels “cannabis is not a drug.”
“No one’s ever [overdosed from cannabis,” he said. People drink. How many people die drinking? You put a bunch of people that don’t like each other in the room and give them alcohol and they kill each other. You give them some cannabis and they start taking selfies or whatever.”
The interview comes about a week after Trump’s first pick for attorney general in the current administration, former Rep. Matt Gaetz (R-FL), reiterated his own support for rescheduling cannabis—suggesting in an interview with a Florida Republican lawmaker that the GOP could win more of the youth vote by embracing marijuana reform.
On marijuana rescheduling, the president did endorse the policy change on the campaign trail. But he’s been publicly silent on the issue since taking office. Gaetz said last month that Trump’s endorsement of a Schedule III reclassification was essentially an attempt to shore up support among young voters rather than a sincere reflection of his personal views about cannabis.
A survey conducted by a GOP pollster affiliated with Trump that was released in April found that a majority of Republicans back a variety of cannabis reforms, including rescheduling. And, notably, they’re even more supportive of allowing states to legalize marijuana without federal interference compared to the average voter.
Meanwhile, Trump picked former Florida Attorney General Pam Bondi (R) to run DOJ, and the Senate confirmed that choice. During her confirmation hearings, Bondi declined to say how she planned to navigate key marijuana policy issues. And as state attorney general, she opposed efforts to legalize medical cannabis.
Adding to the uncertainty around the fate of the rescheduling proposal, Trump’s nominee to lead DEA, Terrance Cole, has previously voiced concerns about the dangers of marijuana and linked its use to higher suicide risk among youth.
During an in-person hearing before the Judiciary Committee in April, Cole said examining the rescheduling proposal will be “one of my first priorities” if he was confirmed for the role, saying it’s “time to move forward” on the stalled process—but again without clarifying what end result he would like to see.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
In a letter to Meta Platforms, Inc., the parent company of Facebook and Instagram, a group of cannabis and psychedelic advocacy organizations, led by Students for Sensible Drug Policy (SSDP), called on the company to end what it describes as “ongoing and disproportionate censorship of content related to cannabis, psychedelics, and harm reduction.”
“Accounts committed to public education, legal and policy advocacy, research dissemination, and harm reduction services — including those of licensed healthcare professionals, nonprofits, and legal businesses — have been routinely shadowbanned, deplatformed, or had their posts removed with little explanation or recourse, despite operating in full compliance with local laws. This suppression is not merely an inconvenience; it is a form of digital marginalization.” — SSDP, in the letter
The groups argue the censorship of cannabis and psychedelics continue amid accelerating overdose deaths and mental health crises, and call on Meta to “end discriminatory bans and shadowbans,” “establish clear, transparent, and consistent content policies that distinguish between promotion of the sale of illegal substances and legitimate drug education and advocacy,” “create a dedicated appeals and accountability process specific to drug-related content that includes community stakeholders and subject-matter experts,” and “engage in regular dialogue with the psychedelic, cannabis, and harm reduction communities to better understand our work and co-create equitable guidelines for content moderation.”
In all, 81 organizations, consisting of students, educators, researchers, advocates, entrepreneurs, and community leaders, joined the letter, calling Meta’s policy “censorship of science, public health, legal, and public policy discourse” and describing the policy as “not an act of neutrality.”
“As the cultural and legal landscapes around these issues evolve,” the letter states, “so too must your policies.”
Florida officials have removed nearly 11,000 packages of hemp products for violating child-protection standards for packaging, labeling, and marketing throughout the state during the Florida Department of Agriculture’s “Operation Safe Summer.”
In a statement, Commissioner of Agriculture Wilton Simpson said the agency has “drawn a hard line in Florida when it comes to protecting our children from dangerous and deceptive hemp products.”
“’Operation Safe Summer’ is our latest effort to crack down on bad actors who think they can skirt the law, ignore public safety, and profit off high-potency, intoxicating hemp products that endanger our children. We will not tire in our commitment to cleaning up this industry, holding violators accountable, and sending a clear message: if you refuse to follow the law, you won’t be doing business in Florida.” — Simpson in a press release
The agency in April and June advised businesses in April and June about the planned enforcement of new Agriculture Department rules around intoxicating hemp-infused products. The new rules, enacted in 2023, include:
Prohibition on specified color additives.
Mandatory child-resistant packaging in accordance with ASTM International D 3475-20, Standard Classification of Child Resistant Packages.
Certificates of analysis must now include laboratory information, the concentration of total delta-9 THC, and confirm the presence or absence of prohibited substances and pathogens.
Restrictions on marketing and advertising of hemp and hemp extract intended for human consumption.
Enhanced labeling requirements, including the use of common household measurements for serving sizes and the provision of a scannable barcode or QR code, must link to the certificate of analysis within three or fewer steps.
Water activity for cannabis flower or leaves must be 0.60 (±0.05).
Since July 2023, the Agriculture Department has uncovered more than 738,000 packages of hemp products in violation of child-protection standards.
The Nebraska Medical Cannabis Commission last week approved emergency regulations to begin accepting medical cannabis applications as soon as Gov. Jim Pillen (R) allows the agency to proceed, the Nebraska Examiner reports. Under the state’s voter-approved medical cannabis law, the commission must start accepting applications by July 1.
The regulations largely mirror a legislative proposal that failed in the legislature last month and would remain in effect for 90 days after being approved by the governor.
Under the medical cannabis law, medical cannabis licensing must begin by October 1, and the emergency regulations would allow for the licensing of cultivators, product manufacturers, dispensaries, and transporters, with individuals or organizations only permitted one type of license.
Under the emergency regulations, only one dispensary would be allowed in each of the state’s 12 District Court Judicial Districts; no dispensary could be located within 1,000 feet of any school, daycare, church or hospital; at least 51% of an applicant’s business or organization must have resided in Nebraska and be a U.S. citizen for at least the past four years; and applicants would have to pay to submit two legible sets of fingerprints to the FBI and the Nebraska State Patrol for a criminal background check.
The regulations do not specify qualifying conditions for medical cannabis access but require that a physician’s recommendation specifies the product being recommended, the recommended dosage and potency, the number of doses, the directions for use, and the name of the patient.
The regulations allow dispensaries to sell oral tablets, capsules, or tinctures; non-sugarcoated gelatinous cubes, gelatinous rectangular cuboids, or lozenges in a cube or rectangular cuboid shape; topical preparations; suppositories; transdermal patches; and liquids or oils for administration using a nebulizer or inhaler. Flower is not permitted under the regulations, neither are infused food or drinks, any products containing artificial or natural flavoring or coloring, or any products that can be smoked or vaped.